{
  "docId": "019de076-7746-74ba-85f9-63c229edc49f",
  "docSlug": "987f138dade45ff64effcbdaa91cb6f6",
  "documentTitle": "Absci | Investor Presentation Deck | 42 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 42,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "why_now",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a visual comparison between small molecule data availability and biologic data scarcity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7746-74ba-85f9-63c229edc49f/5",
  "deckHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f",
  "deckJsonHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f.json",
  "deckAnchorHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.85,
        "x": 0.08,
        "y": 0.45
      },
      "kind": "image",
      "text": "Comparison of small molecule vs biologic data availability",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "119b8111-2631-4409-b7ba-5301e40b43d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.09,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "Small Molecule v. Biologic",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c038701-2f99-45f6-9296-3bb0eb5c2a30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.37,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "Biologics require living organisms to produce drug variants for testing",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e49641c-d213-423f-8622-c1680f5a386a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.72,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "Unlocking the potential of generative AI in biology... requires generating scalable biological data",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9924ab3-7110-4611-b19c-9d00ccf23d2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.85,
        "x": 0.06,
        "y": 0.1
      },
      "kind": "title",
      "text": "Unlocking the potential of generative AI in biology requires scalable biological data",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc69873b-385b-4795-b259-31d5ccbfa63c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.06,
        "y": 0.05
      },
      "kind": "title",
      "text": "WHY HASN'T GENERATIVE AI TRANSFORMED BIOLOGIC DRUG DISCOVERY?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fe1d63a-358c-4f05-87dd-353fdddfbf9d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "b3390757-4780-468f-acb4-7cb298b109ad",
      "evidence": "Visual comparison of data availability between small molecules and biologics",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "bff62f99-f65f-49ec-a72f-e1cdfd4e856e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Why now",
      "beatSlug": null,
      "evidence": "The 'why now' section on page 5 explains the timeliness of AI-driven drug creation",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c9139494-2f86-4c07-856f-1f6b93b76174",
      "evidence": "The problem statement and 'why now' section create a loop highlighting the cost of inaction",
      "position": 0,
      "objective": "What if AI doesn't transform biologics drug discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 11,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0bdbd3d0-6fbe-44fd-ae1a-22c4eca8b50a",
      "evidence": "The thesis headline and solution sections create a loop explaining the importance of AI-driven drug creation",
      "position": 1,
      "objective": "Why is AI-driven drug creation important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 5,
      "from": 5,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "497c955c-690e-48d2-87ba-40efd27e2fb4",
      "evidence": "The 'why now' section creates a loop emphasizing the timeliness of AI-driven drug creation",
      "position": 2,
      "objective": "Why is now the right time for AI-driven drug creation?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.8,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}